HDAC inhibition: A novel therapeutic target for attenuating pulmonary hypertension by regulating Tregs

International Journal of Cardiology

Volumn 198, Issue , 2015, Pages 176-177

  Wang, Jichun ^a   Saren, Gaowa ^b   Jiang, Hong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Histone deacetylases (HDACs); Pulmonary hypertension (PH); Tregs

Indexed keywords

HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE INHIBITOR; TRANSCRIPTION FACTOR FOXP3; TRICHOSTATIN A; VALPROIC ACID; VORINOSTAT;

CD4+ T LYMPHOCYTE; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HISTONE ACETYLATION; HUMAN; LETTER; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REGULATORY T LYMPHOCYTE; TH17 CELL; DRUG DELIVERY SYSTEM; DRUG EFFECTS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY;

DRUG DELIVERY SYSTEMS; HISTONE DEACETYLASE INHIBITORS; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; VENTRICULAR REMODELING;

EID: 84940378947     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.06.172     Document Type: Article

References (15)

1. Y.Y. Huang, Z.F. Fang, X.Q. Hu, and S.H. Zhou HDAC inhibition: a novel therapeutic target for pulmonary hypertension by reducing right ventricular hypertrophy through diverse pathological mechanisms Int. J. Cardiol. 196 2015 125 126
2. J. Wang, X. Hu, and H. Jiang HDAC inhibition: a novel therapeutic target for attenuating myocardial ischemia and reperfusion injury by reversing cardiac remodeling Int. J. Cardiol. 190 2015 126 127
3. M.A. Cavasin, K. Demos-Davies, T.R. Horn, L.A. Walker, D.D. Lemon, N. Birdsey, and et al. Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism Circ. Res. 110 2012 739 748
4. Y.K. Cho, G.H. Eom, H.J. Kee, H.S. Kim, W.Y. Choi, K.I. Nam, and et al. Sodium valproate, a histone deacetylase inhibitor, but not captopril, prevents right ventricular hypertrophy in rats Circ. J. 74 2010 760 770
5. H.J. Bogaard, S. Mizuno, A.A. Hussaini, S. Toldo, A. Abbate, D. Kraskauskas, and et al. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats Am. J. Respir. Crit. Care Med. 183 2011 1402 1410
6. M.R. Nicolls, L. Taraseviciene-Stewart, P.R. Rai, D.B. Badesch, and N.F. Voelkel Autoimmunity and pulmonary hypertension: a perspective Eur. Respir. J. 26 2005 1110 1118
7. M.L. Ormiston, Y. Deng, D.J. Stewart, and D.W. Courtman Innate immunity in the therapeutic actions of endothelial progenitor cells in pulmonary hypertension Am. J. Respir. Cell Mol. Biol. 43 2010 546 554
8. L. Taraseviciene-Stewart, M.R. Nicolls, D. Kraskauskas, R. Scerbavicius, N. Burns, C. Cool, and et al. Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling Am. J. Respir. Crit. Care Med. 175 2007 1280 1289
9. R. Tamosiuniene, W. Tian, G. Dhillon, L. Wang, Y.K. Sung, L. Gera, and et al. Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension Circ. Res. 109 2011 867 879
10. S. Gaowa, W. Zhou, L. Yu, X. Zhou, K. Liao, K. Yang, and et al. Effect of Th17 and Treg axis disorder on outcomes of pulmonary arterial hypertension in connective tissue diseases Mediat. Inflamm. 2014 2014 247372
11. R. Tamosiuniene, and M.R. Nicolls Regulatory T cells and pulmonary hypertension Trends Cardiovasc. Med. 21 2011 166 171
12. B. Li, A. Samanta, X. Song, K.T. Iacono, K. Bembas, R. Tao, and et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression Proc. Natl. Acad. Sci. U. S. A. 104 2007 4571 4576
13. T. Akimova, G. Ge, T. Golovina, T. Mikheeva, L. Wang, J.L. Riley, and et al. Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3 + Tregs Clin. Immunol. 136 2010 348 363
14. C.M. Reilly, M. Thomas, R. Gogal Jr., S. Olgun, A. Santo, R. Sodhi, and et al. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice J. Autoimmun. 31 2008 123 130
15. H.J. Koenen, R.L. Smeets, P.M. Vink, E. van Rijssen, A.M. Boots, and I. Joosten Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells Blood 112 2008 2340 2352